Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 6c/Share
Tweet Send to a FriendGet Alerts INO Hot Sheet
Price: $0.71 +4.41%
Revenue Growth %: -31.3%
Financial Fact:
License fee and milestone revenue from affiliated entity: 106.25K
Today's EPS Names:
CSS, STV, GIGM, More
Revenue Growth %: -31.3%
Financial Fact:
License fee and milestone revenue from affiliated entity: 106.25K
Today's EPS Names:
CSS, STV, GIGM, More
Trade INO Now!
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
- China TechFaith (CNTF) Swings to Q1 Profitl; Guides Q2 Sales
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
